{"product_id":"the-maudsley-practice-guidelines-for-physical-health-conditions-in-psychiatry-isbn-9781119554202","title":"The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry","description":"\u003cp\u003e\u003cb\u003eLearn to improve your assessment, investigation, and management of physical health conditions in people with severe mental illness\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eThe Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry\u003c\/i\u003e offers psychiatric and general practitioners an evidence-based and practical guide for the appropriate assessment, investigation, and management of common physical health conditions seen in people with severe mental illness. Written by a renowned team of respected experts in medicine, surgery, pharmacy, dietetics, physiotherapy, and psychiatry, the book bridges the gap between psychiatric and physical health services for the severely mentally ill.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eThe Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry\u003c\/i\u003e also provides practitioners with expert guidance on making effective referrals to other medical and surgical subspecialties, telling readers what information subspecialties would expect to receive. Its use will improve the quality of clinical care received by mentally ill patients and, by promoting a holistic approach to treatment that considers both body and mind, will enhance the therapeutic relationship between patient and practitioner.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eThe Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry\u003c\/i\u003e covers the following:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eGuidance on assessment and management of well over a hundred different medical and surgical presentations commonly seen in people with serious mental illness\u003c\/li\u003e \u003cli\u003eManagement of physical health emergencies in a psychiatric setting\u003c\/li\u003e \u003cli\u003eEvidence-based approaches to management of physical side effects of psychiatric medications\u003c\/li\u003e \u003cli\u003eAdvice on approaches to promote a healthy lifestyle in people with serious mental illness, such as smoking cessation and changes to diet and physical activity\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003ePerfect for both psychiatrists and general practitioners who wish to improve the quality of care they provide to people with serious mental illness, \u003ci\u003eThe Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry\u003c\/i\u003e will be of use to anyone setting out to navigate the divide between the treatment of psychiatric and physical health conditions.\u003c\/p\u003e \u003cp\u003ePreface xxiii\u003c\/p\u003e \u003cp\u003eList of Abbreviations xxv\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1 Cardiology 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 1 Tachycardia 3\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eGuy Hindley, Eromona Whiskey, Nicholas Gall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eSinus tachycardia 3\u003c\/p\u003e \u003cp\u003eAtrial fibrillation 4\u003c\/p\u003e \u003cp\u003eSupraventricular tachycardia 4\u003c\/p\u003e \u003cp\u003eVentricular tachycardia 6\u003c\/p\u003e \u003cp\u003eDiagnostic principles 6\u003c\/p\u003e \u003cp\u003eManagement 10\u003c\/p\u003e \u003cp\u003eReferences 14\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 2 Bradycardia 17\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEleanor Croft, Nicholas Gall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnosis 19\u003c\/p\u003e \u003cp\u003eManagement and when to refer to a specialist 21\u003c\/p\u003e \u003cp\u003eReferences 22\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 3 QT Interval Prolongation 23\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eGuy Hindley, Nicholas Gall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePrescribing QTc‐prolonging medication 27\u003c\/p\u003e \u003cp\u003eDiagnostic principles 28\u003c\/p\u003e \u003cp\u003eManagement 29\u003c\/p\u003e \u003cp\u003eReferences 32\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 4 Syncope 35\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eLuke Vano, Nicholas Gall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eCauses of syncope 35\u003c\/p\u003e \u003cp\u003eSyncope and serious mental illness 36\u003c\/p\u003e \u003cp\u003eDiagnostic principles 36\u003c\/p\u003e \u003cp\u003eDiagnosis and management 38\u003c\/p\u003e \u003cp\u003eReferences 39\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 5 Hypertension 41\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eLuke Vano, Toby Pillinger, J. Kennedy Cruickshank\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 43\u003c\/p\u003e \u003cp\u003eDiagnosis 44\u003c\/p\u003e \u003cp\u003eManagement 45\u003c\/p\u003e \u003cp\u003eReferences 48\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 6 Postural Hypotension 51\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eToby Pillinger, Ian Osborne, Thomas Ernst, J. Kennedy Cruickshank\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 53\u003c\/p\u003e \u003cp\u003eManagement 54\u003c\/p\u003e \u003cp\u003eReferences 58\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 7 Peripheral Oedema 59\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eThomas Whitehurst, Theresa McDonagh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 60\u003c\/p\u003e \u003cp\u003eManagement 66\u003c\/p\u003e \u003cp\u003eReferences 67\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 8 Myocarditis 71\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eThomas Whitehurst, Theresa McDonagh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 71\u003c\/p\u003e \u003cp\u003eManagement 75\u003c\/p\u003e \u003cp\u003eClozapine‐induced myocarditis 75\u003c\/p\u003e \u003cp\u003eReferences 77\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 9 Hypercholesterolaemia 79\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDipen Patel, Toby Pillinger, Narbeh Melikian\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 80\u003c\/p\u003e \u003cp\u003eDiagnostic criteria 81\u003c\/p\u003e \u003cp\u003eManagement 81\u003c\/p\u003e \u003cp\u003eReferences 84\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 10 Physical Activity 85\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eGarcia Ashdown-Franks, Brendon Stubbs\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePhysical activity and serious mental illness 85\u003c\/p\u003e \u003cp\u003eHow much physical activity and exercise should people be doing? 86\u003c\/p\u003e \u003cp\u003ePractical tips 87\u003c\/p\u003e \u003cp\u003eMessages to include in discussions with patients 87\u003c\/p\u003e \u003cp\u003eReferences 88\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2 Endocrinology 91\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 11 Diabetes Mellitus 93\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eYuya Mizuno, Toby Pillinger, Dan Siskind, Sophie Harris\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 93\u003c\/p\u003e \u003cp\u003eManagement 97\u003c\/p\u003e \u003cp\u003eReferences 102\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 12 Thyroid Disease 105\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eHarriet Quigley, Jackie Gilbert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eHypothyroidism 105\u003c\/p\u003e \u003cp\u003eDiagnostic principles 107\u003c\/p\u003e \u003cp\u003eManagement 110\u003c\/p\u003e \u003cp\u003eHyperthyroidism 111\u003c\/p\u003e \u003cp\u003eDiagnostic principles 112\u003c\/p\u003e \u003cp\u003eManagement 113\u003c\/p\u003e \u003cp\u003eReferences 114\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 13 Hyperprolactinaemia 117\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJohn Lally, Toby Pillinger, Olubanke Dzahini, Sophie Harris\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 119\u003c\/p\u003e \u003cp\u003eManagement and when to refer to a specialist 121\u003c\/p\u003e \u003cp\u003eHyperprolactinaemia and osteoporosis risk in serious mental illness 122\u003c\/p\u003e \u003cp\u003eHyperprolactinaemia and cancer risk 123\u003c\/p\u003e \u003cp\u003eReferences 123\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 14 Obesity 125\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eYuya Mizuno, Toby Pillinger, Dan Siskind, Ian Osborne, Kate Moffat, Donal O’Shea\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eMonitoring 127\u003c\/p\u003e \u003cp\u003ePrevention and treatment of weight gain 129\u003c\/p\u003e \u003cp\u003eReferences 134\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3 Haematology 137\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 15 Anaemia 139\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSanjena Mithra, Aleksander Mijovic\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 140\u003c\/p\u003e \u003cp\u003eManagement and referral pathways 143\u003c\/p\u003e \u003cp\u003eReferences 145\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 16 Neutropenia 147\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJohn Lally, Toby Pillinger, Aleksander Mijovic\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDrug‐induced neutropenia and agranulocytosis 149\u003c\/p\u003e \u003cp\u003eDiagnostic principles 150\u003c\/p\u003e \u003cp\u003eManagement 151\u003c\/p\u003e \u003cp\u003eReferences 153\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 17 Thrombocytopenia 155\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSanjena Mithra, Aleksander Mijovic\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 156\u003c\/p\u003e \u003cp\u003eManagement and when to refer 158\u003c\/p\u003e \u003cp\u003eReferences 158\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 18 Venous Thromboembolism and Anticoagulation 159\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eHelen Doolittle, Lara Roberts, Roopen Arya\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eRisk factors 159\u003c\/p\u003e \u003cp\u003eProphylaxis 161\u003c\/p\u003e \u003cp\u003eDiagnosis 162\u003c\/p\u003e \u003cp\u003eManagement 164\u003c\/p\u003e \u003cp\u003eReferences 168\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 4 Gastroenterology 169\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 19 Gastro‐oesophageal Reflux and Peptic Ulcer Disease 171\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eLuke Vano, Seema Varma, John O’Donohue\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eGastro‐oesophageal reflux disease 171\u003c\/p\u003e \u003cp\u003ePeptic ulcer disease 176\u003c\/p\u003e \u003cp\u003eReferences 178\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 20 Gastrointestinal Bleeding 181\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDouglas Corrigall, David Dewar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 183\u003c\/p\u003e \u003cp\u003eManagement 185\u003c\/p\u003e \u003cp\u003eReferences 188\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 21 Nausea and Vomiting 191\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMary Denholm, Matthew Cheetham\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 193\u003c\/p\u003e \u003cp\u003eManagement 195\u003c\/p\u003e \u003cp\u003eReferences 198\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 22 Dysphagia 199\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMary Denholm, Jason Dunn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eCauses of dysphagia in the general population 199\u003c\/p\u003e \u003cp\u003eDiagnostic principles 200\u003c\/p\u003e \u003cp\u003eManagement 203\u003c\/p\u003e \u003cp\u003eOesophageal cancer in psychiatric populations 203\u003c\/p\u003e \u003cp\u003eDysphagia in the elderly 204\u003c\/p\u003e \u003cp\u003eReferences 204\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 23 Deranged Liver Function Tests 207\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJohn Lally, Aisling Considine, Kosh Agarwal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 207\u003c\/p\u003e \u003cp\u003eManagement 212\u003c\/p\u003e \u003cp\u003eReferences 213\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 24 Alcohol and Physical Health 215\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMusa Sami, Joseph Cooney, Michael Heneghan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eWhat is harmful use? 215\u003c\/p\u003e \u003cp\u003ePhysical complications of alcohol use 216\u003c\/p\u003e \u003cp\u003eApproach to the patient with suspected alcohol misuse 217\u003c\/p\u003e \u003cp\u003eManagement 220\u003c\/p\u003e \u003cp\u003eReferences 222\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 25 Unintentional Weight Loss 223\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMary Denholm, John O’Donohue\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 225\u003c\/p\u003e \u003cp\u003eManagement 227\u003c\/p\u003e \u003cp\u003eReferences 227\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 26 Dry Mouth 229\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEnrico D’Ambrosio, Andrea Falsetti, Stephen Challacombe\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 231\u003c\/p\u003e \u003cp\u003eManagement 231\u003c\/p\u003e \u003cp\u003eReferences 232\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 27 Hypersalivation 235\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEnrico D’Ambrosio, Andrea Falsetti, Toby Pillinger, Stephen Challacombe\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 235\u003c\/p\u003e \u003cp\u003eManagement 236\u003c\/p\u003e \u003cp\u003eReferences 239\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 28 Constipation 241\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJohn Lally, Toby Pillinger, Kalliopi Vallianatou, Immo Weichert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 243\u003c\/p\u003e \u003cp\u003eManagement 244\u003c\/p\u003e \u003cp\u003eReferences 249\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 5 Renal and Urology 251\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 29 Urinary Retention 253\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAtheeshaan Arumuham, Vimoshan Arumuham\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eUrinary retention and serious mental illness 253\u003c\/p\u003e \u003cp\u003eDiagnostic principles 254\u003c\/p\u003e \u003cp\u003eManagement 256\u003c\/p\u003e \u003cp\u003eReferences 256\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 30 Urinary Incontinence 259\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAtheeshaan Arumuham, Vimoshan Arumuham\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 261\u003c\/p\u003e \u003cp\u003eManagement 262\u003c\/p\u003e \u003cp\u003eReferences 264\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 31 Polyuria 267\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAtheeshaan Arumuham, Toby Pillinger, Benjamin Whitelaw\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 268\u003c\/p\u003e \u003cp\u003eManagement 269\u003c\/p\u003e \u003cp\u003eReferences 271\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 32 Sodium Derangement 273\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAtheeshaan Arumuham, Peter Conlon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 274\u003c\/p\u003e \u003cp\u003eManagement 276\u003c\/p\u003e \u003cp\u003eReferences 277\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 33 Potassium Derangement 279\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEllis Onwordi, Peter Conlon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eHyperkalaemia 279\u003c\/p\u003e \u003cp\u003eHypokalaemia 282\u003c\/p\u003e \u003cp\u003eReferences 285\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 34 Chronic Kidney Disease 287\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEllis Onwordi, Toby Pillinger, Anne Connolly, Peter Conlon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 289\u003c\/p\u003e \u003cp\u003eManagement 291\u003c\/p\u003e \u003cp\u003eReferences 295\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 6 Sexual and Reproductive Health 297\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 35 Sexual Dysfunction 299\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRudiger Pittrof\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eAssessment of a patient with sexual dysfunction 299\u003c\/p\u003e \u003cp\u003eManagement 301\u003c\/p\u003e \u003cp\u003eReferences 304\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 36 Contraception 307\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eNeha Pathak, Usha Kumar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eClinical approach 308\u003c\/p\u003e \u003cp\u003eContraceptive options 308\u003c\/p\u003e \u003cp\u003eEthical and legal considerations 312\u003c\/p\u003e \u003cp\u003eWhen to refer 313\u003c\/p\u003e \u003cp\u003eSpecial considerations in patients with serious mental illness 313\u003c\/p\u003e \u003cp\u003eReferences 314\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 37 Infertility 317\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRudiger Pittrof\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eAddressing infertility in psychiatric practice 317\u003c\/p\u003e \u003cp\u003eOnward referral and further tests for infertility 318\u003c\/p\u003e \u003cp\u003eInfertility treatments 318\u003c\/p\u003e \u003cp\u003eReferences 318\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 38 Sexually Transmitted Infection 319\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eHarriet Le Voir, Rudiger Pittrof\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eHistory 319\u003c\/p\u003e \u003cp\u003eSTI testing in psychiatry 320\u003c\/p\u003e \u003cp\u003eDetermining urgency of clinical action\/referral 321\u003c\/p\u003e \u003cp\u003eReferral to sexual health services 322\u003c\/p\u003e \u003cp\u003eReferences 324\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 7 Infectious Diseases 325\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 39 Pneumonia 327\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEmma McGuire, Loren Bailey, Peter Saunders, Meera Chand\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePneumonia and serious mental illness 329\u003c\/p\u003e \u003cp\u003eDiagnostic principles 329\u003c\/p\u003e \u003cp\u003eManagement 332\u003c\/p\u003e \u003cp\u003eReferences 335\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 40 Influenza 337\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAnna Riddell, Eithne MacMahon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 338\u003c\/p\u003e \u003cp\u003eManagement 339\u003c\/p\u003e \u003cp\u003ePreventing spread of influenza 341\u003c\/p\u003e \u003cp\u003eReferences 342\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 41 Urinary Tract Infection 343\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSian Cooper, Conor Maguire\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eUrinary tract infection and serious mental illness 344\u003c\/p\u003e \u003cp\u003eDiagnostic principles 344\u003c\/p\u003e \u003cp\u003eManagement 347\u003c\/p\u003e \u003cp\u003eReferences 350\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 42 Gastroenteritis 351\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMaria Krutikov, Luke Snell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 351\u003c\/p\u003e \u003cp\u003eManagement 354\u003c\/p\u003e \u003cp\u003eReferences 356\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 43 Viral Hepatitis 357\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eKlara Doherty, Aisling Considine, Kosh Agarwal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eHepatitis B 357\u003c\/p\u003e \u003cp\u003eHepatitis C 361\u003c\/p\u003e \u003cp\u003eReferences 364\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 44 Tuberculosis 365\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSakib Rokadiya, Adrian R. Martineau\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 366\u003c\/p\u003e \u003cp\u003eManagement 369\u003c\/p\u003e \u003cp\u003eReferences 371\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 45 Human Immunodeficiency Virus 373\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRebecca Marcus, Jessica Gaddie, Toby Pillinger, Ben Spencer, Kalliopi Vallianatou, Rudiger Pittrof\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eTesting for HIV 374\u003c\/p\u003e \u003cp\u003eHIV and the central nervous system 374\u003c\/p\u003e \u003cp\u003eAntiretroviral therapy 375\u003c\/p\u003e \u003cp\u003eReferences 380\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 8 Respiratory 383\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 46 Smoking Cessation 385\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eHarriet Quigley, Mary Yates, John Moxham\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIdentifying those who want to stop smoking and degree of nicotine dependence 385\u003c\/p\u003e \u003cp\u003eApproaches to smoking cessation 387\u003c\/p\u003e \u003cp\u003eReferences 392\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 47 Chronic Obstructive Pulmonary Disease 395\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMary Docherty, Jenny Docherty, Peter Saunders\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eCommon causes of COPD in the general population and patients with serious mental illness 395\u003c\/p\u003e \u003cp\u003eThe asthma–COPD overlap 396\u003c\/p\u003e \u003cp\u003eDiagnostic principles 397\u003c\/p\u003e \u003cp\u003eManagement 400\u003c\/p\u003e \u003cp\u003eReferences 403\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 48 Asthma 405\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMary Docherty, Jenny Docherty, Peter Saunders\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eCauses in the general population and people with serious mental illness 405\u003c\/p\u003e \u003cp\u003eDiagnostic principles 406\u003c\/p\u003e \u003cp\u003eManagement 409\u003c\/p\u003e \u003cp\u003eReferences 412\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 49 Obstructive Sleep Apnoea 413\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eNicholas Meyer, Hugh Selsick, Kai Lee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 414\u003c\/p\u003e \u003cp\u003eManagement 415\u003c\/p\u003e \u003cp\u003eReferences 416\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 9 Neurology 419\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 50 Delirium 421\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eLuke Jelen, Sean Cross\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eDiagnostic principles \u003c\/b\u003e421\u003c\/p\u003e \u003cp\u003eManagement 426\u003c\/p\u003e \u003cp\u003eReferences 429\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 51 Autoimmune Encephalitis 431\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAdam Al-Diwani, Julia Thompson, Sarosh Irani\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eAutoimmune disease mechanisms 431\u003c\/p\u003e \u003cp\u003eClinical approach 432\u003c\/p\u003e \u003cp\u003eManagement 437\u003c\/p\u003e \u003cp\u003eReferences 439\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 52 Catatonia 441\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJonathan P. Rogers, Ali Amad\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 442\u003c\/p\u003e \u003cp\u003eManagement 444\u003c\/p\u003e \u003cp\u003eReferences 448\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 53 Seizure Disorders 451\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEmanuele F. Osimo, Brian Sweeney\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eAcute seizure 452\u003c\/p\u003e \u003cp\u003ePsychiatric comorbidity in people with epilepsy 455\u003c\/p\u003e \u003cp\u003ePsychiatric side effects of antiepileptic drugs 457\u003c\/p\u003e \u003cp\u003ePsychiatric drug therapy in people with epilepsy 457\u003c\/p\u003e \u003cp\u003ePsychogenic non‐epileptic seizures 458\u003c\/p\u003e \u003cp\u003eEpilepsy surgery 459\u003c\/p\u003e \u003cp\u003eEpilepsy and learning disability 459\u003c\/p\u003e \u003cp\u003eReferences 459\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 54 Headache 461\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eInes Carreira Figueiredo, Nazia Karsan, Peter Goadsby\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 463\u003c\/p\u003e \u003cp\u003eManagement 466\u003c\/p\u003e \u003cp\u003eReferences 468\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 55 Disorders of Sleep and Circadian Rhythm 471\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eNicholas Meyer, Hugh Selsick\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDefinitions of common sleep disorders in psychiatric populations 471\u003c\/p\u003e \u003cp\u003eDiagnostic principles 474\u003c\/p\u003e \u003cp\u003eManagement 476\u003c\/p\u003e \u003cp\u003eReferences 477\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 56 Extrapyramidal Side Effects 479\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eGraham Blackman, R. John Dobbs, Sylvia Dobbs\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eClinical approach 480\u003c\/p\u003e \u003cp\u003eManagement 482\u003c\/p\u003e \u003cp\u003eReferences 483\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 57 Tardive Dyskinesia 485\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eGraham Blackman, Toby Pillinger, R. John Dobbs, Sylvia Dobbs\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eClinical approach 486\u003c\/p\u003e \u003cp\u003eManagement 487\u003c\/p\u003e \u003cp\u003eReferences 489\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 58 Tremor 491\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eGraham Blackman, R. John Dobbs, Sylvia Dobbs\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eClinical approach 491\u003c\/p\u003e \u003cp\u003eManagement 494\u003c\/p\u003e \u003cp\u003eReferences 496\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 10 Rheumatology and Musculoskeletal Health 497\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 59 Low Back Pain 499\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJennifer Ireland, Matthew Cheetham\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 500\u003c\/p\u003e \u003cp\u003eManagement 502\u003c\/p\u003e \u003cp\u003eReferences 503\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 60 Arthritis 505\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSarah Griffin, Joseph Nathan, Richard Campbell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eClinical approach 510\u003c\/p\u003e \u003cp\u003eManagement 512\u003c\/p\u003e \u003cp\u003eReferences 512\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 11 Ophthalmology 515\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 61 Eye Disease 517\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eErnest Iakovlev, Radwan Almousa\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eClinical approach to a patient with visual disturbance or orbital\/periorbital disorders 517\u003c\/p\u003e \u003cp\u003eDisorders of the eyelids 522\u003c\/p\u003e \u003cp\u003eDisorders of the conjunctiva 526\u003c\/p\u003e \u003cp\u003eDisorders of the cornea 529\u003c\/p\u003e \u003cp\u003eReferences 533\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 12 Obstetrics and Gynaecology 535\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 62 Pregnancy 537\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eKatherine Beck, Ruth Cochrane, Louise M. Howard\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eThe pre‐conception period 538\u003c\/p\u003e \u003cp\u003eDuring pregnancy 539\u003c\/p\u003e \u003cp\u003ePsychiatric medication in pregnancy 543\u003c\/p\u003e \u003cp\u003ePostpartum psychosis 547\u003c\/p\u003e \u003cp\u003eElectroconvulsive therapy in pregnancy 547\u003c\/p\u003e \u003cp\u003eReferences 548\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 63 Menopause 551\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDeirdre Lundy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePhysiology and symptoms of perimenopause 551\u003c\/p\u003e \u003cp\u003eClinical approach 552\u003c\/p\u003e \u003cp\u003eTreatment 553\u003c\/p\u003e \u003cp\u003eReferences 556\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 13 Dermatology 559\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 64 General Dermatology 561\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJonathan Kentley, Ruth Taylor, Anthony Bewley\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eInfectious skin disease 561\u003c\/p\u003e \u003cp\u003eNon‐infectious skin disease 564\u003c\/p\u003e \u003cp\u003eReferences 566\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 65 Psychodermatology 569\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJonathan Kentley, Ruth Taylor, Anthony Bewley\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePsychiatric disorders with skin manifestations 569\u003c\/p\u003e \u003cp\u003ePsychophysiological conditions 571\u003c\/p\u003e \u003cp\u003eSecondary psychological disorders 571\u003c\/p\u003e \u003cp\u003eCutaneous sensory disorders 572\u003c\/p\u003e \u003cp\u003eReferences 572\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 14 Electroconvulsive Therapy 573\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 66 Electroconvulsive Therapy 575\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJames Kelly, Mariese Cooper, Mario Juruena\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndications and contraindications 575\u003c\/p\u003e \u003cp\u003eThe ECT procedure 576\u003c\/p\u003e \u003cp\u003ePhysiological effects of ECT 576\u003c\/p\u003e \u003cp\u003ePre‐ECT assessment 578\u003c\/p\u003e \u003cp\u003eSafety of ECT 579\u003c\/p\u003e \u003cp\u003eECT prescribing 579\u003c\/p\u003e \u003cp\u003eGuidance for the doctor administering ECT 579\u003c\/p\u003e \u003cp\u003eSide effects of ECT 580\u003c\/p\u003e \u003cp\u003eSpecial patient groups 581\u003c\/p\u003e \u003cp\u003eReferences 581\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 15 Emergencies 583\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 67 Chest Pain 585\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eLuke Vano, Immo Weichert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 586\u003c\/p\u003e \u003cp\u003eManagement 590\u003c\/p\u003e \u003cp\u003eInformation to provide in a ‘chest pain’ referral to medical services 591\u003c\/p\u003e \u003cp\u003eReferences 591\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 68 Acute Shortness of Breath 593\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMartin Osugo, Toby Pillinger, Vivek Srivastava\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 593\u003c\/p\u003e \u003cp\u003eManagement 595\u003c\/p\u003e \u003cp\u003eReferences 596\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 69 Acute Coronary Syndrome 597\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eLaura O’Sullivan, Narbeh Melikian\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 598\u003c\/p\u003e \u003cp\u003eManagement 602\u003c\/p\u003e \u003cp\u003eReferences 603\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 70 Arrhythmia 605\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMartin Osugo, Nicholas Gall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eTachycardia 605\u003c\/p\u003e \u003cp\u003eBradycardia 605\u003c\/p\u003e \u003cp\u003eReference 608\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 71 Hypertensive Crisis 609\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eLuke Vano, J. Kennedy Cruickshank\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 609\u003c\/p\u003e \u003cp\u003eManagement 610\u003c\/p\u003e \u003cp\u003eReferences 611\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 72 Sepsis 613\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eLaura O’Sullivan, Immo Weichert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eWhen to think sepsis 613\u003c\/p\u003e \u003cp\u003eSeptic shock 614\u003c\/p\u003e \u003cp\u003eManagement 614\u003c\/p\u003e \u003cp\u003ePost‐sepsis syndrome 615\u003c\/p\u003e \u003cp\u003eReferences 616\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 73 Acute Kidney Injury 617\u003cbr\u003e\u003c\/b\u003e\u003ci\u003ePhillipa Brothwood, Toby Pillinger, Anne Connolly, Peter Conlon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eCategorisation of acute kidney injury 617\u003c\/p\u003e \u003cp\u003eDiagnostic principles 620\u003c\/p\u003e \u003cp\u003eManagement 622\u003c\/p\u003e \u003cp\u003ePsychiatric medication and acute kidney injury 622\u003c\/p\u003e \u003cp\u003eReferences 623\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 74 Diabetic Emergencies 625\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eToby Pillinger, Yuya Mizuno, Sophie Harris\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eHypoglycaemia 625\u003c\/p\u003e \u003cp\u003eDiabetic ketoacidosis 626\u003c\/p\u003e \u003cp\u003eHyperosmolar hyperglycaemic state 627\u003c\/p\u003e \u003cp\u003eReferences 627\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 75 Acute Upper Gastrointestinal Bleeding 629\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDouglas Corrigall, David Dewar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eSigns of acute upper gastrointestinal bleeding 629\u003c\/p\u003e \u003cp\u003eWaiting for transfer 629\u003c\/p\u003e \u003cp\u003eHanding over to the acute medical team 630\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 76 Status Epilepticus 631\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEmanuele F. Osimo, Brian Sweeney\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 77 Anaphylaxis 633\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJames Kelly, Immo Weichert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eManagement 633\u003c\/p\u003e \u003cp\u003eReferences 636\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 78 Reduced Consciousness and Coma 637\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJames Kelly, Immo Weichert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eClinical approach 637\u003c\/p\u003e \u003cp\u003eReferences 640\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 79 Thyroid Emergencies 641\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eHarriet Quigley, Jackie Gilbert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eHypothyroid crisis\/myxoedema coma 641\u003c\/p\u003e \u003cp\u003eHyperthyroid crisis\/thyroid storm 642\u003c\/p\u003e \u003cp\u003eReferences 643\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 80 Head Injury 645\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSusie Bradwell, Sophie Williams, Joanna Manson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eClinical approach 645\u003c\/p\u003e \u003cp\u003eTypes of intracranial haemorrhage 649\u003c\/p\u003e \u003cp\u003eReferences 650\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 81 Acute Meningitis and Infective Encephalitis 651\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eHina Khan, Brian Sweeney\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eMeningitis 651\u003c\/p\u003e \u003cp\u003eInfective encephalitis 653\u003c\/p\u003e \u003cp\u003eReferences 655\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 82 Stroke and Transient Ischaemic Attack 657\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eToby Pillinger, James Teo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eStroke 657\u003c\/p\u003e \u003cp\u003eDiagnostic principles 658\u003c\/p\u003e \u003cp\u003eManagement 659\u003c\/p\u003e \u003cp\u003eTransient Ischaemic Attack 660\u003c\/p\u003e \u003cp\u003eDiagnostic principles 660\u003c\/p\u003e \u003cp\u003eManagement 661\u003c\/p\u003e \u003cp\u003eReferences 661\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 83 Overdose 663\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eStephen Kaar, Immo Weichert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eGeneral principles 663\u003c\/p\u003e \u003cp\u003eInformation gathering 664\u003c\/p\u003e \u003cp\u003eEmergency assessment and management 664\u003c\/p\u003e \u003cp\u003eSpecific scenarios 667\u003c\/p\u003e \u003cp\u003eManagement of a person who refuses admission to hospital after an overdose 670\u003c\/p\u003e \u003cp\u003eReferences 670\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 84 Acute Dystonia 673\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJonathan P. Rogers, R. John Dobbs, Sylvia Dobbs\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 673\u003c\/p\u003e \u003cp\u003eManagement 675\u003c\/p\u003e \u003cp\u003eReferences 677\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 85 Neuroleptic Malignant Syndrome 679\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRobert A. McCutcheon, James Kelly, Toby Pillinger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 679\u003c\/p\u003e \u003cp\u003eManagement 680\u003c\/p\u003e \u003cp\u003eReferences 681\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 86 Serotonin Syndrome 683\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRobert A. McCutcheon, James Kelly, Toby Pillinger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDiagnostic principles 683\u003c\/p\u003e \u003cp\u003eManagement 684\u003c\/p\u003e \u003cp\u003eReferences 685\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 87 Emergencies in Obstetrics and Gynaecology 687\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eHanine Fourie, Ruth Cochrane\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eMaternal collapse 689\u003c\/p\u003e \u003cp\u003ePre‐eclampsia 689\u003c\/p\u003e \u003cp\u003eMajor obstetric haemorrhage 691\u003c\/p\u003e \u003cp\u003eAmniotic fluid embolism 691\u003c\/p\u003e \u003cp\u003eEctopic pregnancy 691\u003c\/p\u003e \u003cp\u003eMiscarriage 693\u003c\/p\u003e \u003cp\u003eHyperemesis gravidarum 694\u003c\/p\u003e \u003cp\u003eOvarian cyst accidents 695\u003c\/p\u003e \u003cp\u003ePelvic inflammatory disease 697\u003c\/p\u003e \u003cp\u003eReferences 697\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 88 The Acute Abdomen 699\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSophie Williams, Joanna Manson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eHistory 699\u003c\/p\u003e \u003cp\u003eCauses of the acute abdomen based on pain location 702\u003c\/p\u003e \u003cp\u003eExamination 705\u003c\/p\u003e \u003cp\u003eInvestigations 706\u003c\/p\u003e \u003cp\u003eOnward referral 706\u003c\/p\u003e \u003cp\u003eReferences 707\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 89 The ABCDE Approach 709\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eToby Pillinger, Immo Weichert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eFirst steps 709\u003c\/p\u003e \u003cp\u003eAirway (A) 711\u003c\/p\u003e \u003cp\u003eBreathing (B) 711\u003c\/p\u003e \u003cp\u003eCirculation (C) 711\u003c\/p\u003e \u003cp\u003eDisability (D) 711\u003c\/p\u003e \u003cp\u003eExposure (E) 712\u003c\/p\u003e \u003cp\u003eReferences 712\u003c\/p\u003e \u003cp\u003eIndex 713\u003c\/p\u003e  \u003cp\u003e\u003cb\u003eDavid M. Taylor, BSc, MSc, PhD, FCMHP, FFRPS, FRPharmS, FRCP (Edin),\u003c\/b\u003e is Director of Pharmacy and Pathology at the Maudsley Hospital; Professor of Psychopharmacology at King's College, London, UK. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eFiona Gaughran\u003c\/b\u003e, \u003cb\u003eMD, FRCP(I), FRCP (Lon), FRCP (Edin), FRCPsych, FHEA,\u003c\/b\u003e is Director of Research and Development at South London and Maudsley NHS Foundation Trust, where she is Lead Consultant for the National Psychosis Service; Reader in Psychopharmacology and Physical Health at King's College, London, UK. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eToby Pillinger, MA (Oxon), BM BCh, MRCP, PhD,\u003c\/b\u003e is an Academic Clinical fellow at the Institute of Psychiatry, Psychology and Neuroscience, King's College, London; South London and Maudsley NHS Foundation Trust, London, UK.\t   \u003c\/p\u003e\u003cp\u003e\u003cb\u003eLearn to Improve Your Assessment, Investigation, and Management of Physical Health Conditions in People with Severe Mental Illness\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e\u003ci\u003eThe Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry\u003c\/i\u003e offers psychiatric and general practitioners an evidence-based and practical guide for the appropriate assessment, investigation, and management of common physical health conditions seen in people with severe mental illness. Written by a renowned team of respected experts in medicine, surgery, pharmacy, dietetics, physiotherapy, and psychiatry, the book bridges the gap between psychiatric and physical health services for the severely mentally ill. \u003c\/p\u003e\u003cp\u003e\u003ci\u003eThe Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry\u003c\/i\u003e also provides practitioners with expert guidance on making effective referrals to other medical and surgical subspecialties, telling readers what information subspecialties would expect to receive. Its use will improve the quality of clinical care received by mentally ill patients and, by promoting a holistic approach to treatment that considers both body and mind, will enhance the therapeutic relationship between patient and practitioner. \u003c\/p\u003e\u003cp\u003e\u003ci\u003eThe Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry\u003c\/i\u003e covers the following: \u003c\/p\u003e\u003cul\u003e \u003cli\u003eGuidance on assessment and management of well over a hundred different medical and surgical presentations commonly seen in people with serious mental illness\u003c\/li\u003e \u003cli\u003eManagement of physical health emergencies in a psychiatric setting\u003c\/li\u003e \u003cli\u003eEvidence-based approaches to management of physical side effects of psychiatric medications\u003c\/li\u003e \u003cli\u003eAdvice on approaches to promote a healthy lifestyle in people with serious mental illness, such as smoking cessation and changes to diet and physical activity\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003ePerfect for both psychiatrists and general practitioners who wish to improve the quality of care they provide to people with serious mental illness, \u003ci\u003eThe Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry\u003c\/i\u003e will be of use to anyone setting out to navigate the divide between the treatment of psychiatric and physical health conditions.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47990285697253,"sku":"NP9781119554202","price":47.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781119554202.jpg?v=1761787204","url":"https:\/\/k12savings.com\/es\/products\/the-maudsley-practice-guidelines-for-physical-health-conditions-in-psychiatry-isbn-9781119554202","provider":"K12savings","version":"1.0","type":"link"}